Eli Lilly PM onboarding first 90 days what to expect 2026

Eli Lilly PM Onboarding: First 90 Days What to Expect 2026

TL;DR

The first 90 days as a product manager at Eli Lilly are not about launching features—they’re about earning trust, mapping stakeholders, and mastering compliance context. You will rotate through medical, commercial, and regulatory teams, attend mandatory GxP training, and deliver one cross-functional readiness review by day 60. The problem isn’t your pace—it’s your pattern of escalation. Most fail not from lack of effort, but from premature solutioning.

Who This Is For

This is for newly hired or即将-onboarded product managers joining Eli Lilly in 2026, particularly those transitioning from tech or consumer tech into regulated pharma. It’s also for internal candidates moving from commercial or medical affairs into formal PM roles. If you’ve never worked under FDA oversight or aligned a roadmap to clinical trial timelines, this applies. The challenge isn’t learning the science—it’s unlearning Silicon Valley urgency.

What does the Eli Lilly PM onboarding timeline look like in the first 90 days?

The first 90 days are structured as a compliance-gated ramp: days 1–15 are training and access provisioning, days 16–45 are stakeholder immersion, days 46–75 are co-ownership of a sub-roadmap, and days 76–90 are independent ownership of a phase-gated deliverable.

In Q1 2025, a hiring manager paused a new PM’s progression because they requested Jira access on day 3. The mistake wasn’t the ask—it was the signal: urgency without context. At Lilly, you don’t “move fast”; you move with traceability.

Not all onboarding paths are equal. External hires in digital therapeutics go through 18 hours of 21 CFR Part 11 training; internal transfers need only 6. Your start date does not mark Day 1 of contribution—it marks Day 1 of observation.

The framework isn’t “30-60-90”—it’s “assess-align-act.” By day 30, you must name every member of your core team and their reporting lines. By day 60, you must have facilitated a therapeutic area (TA) alignment session. By day 90, you must close a documented gap in the product risk log.

Your manager will not measure you on output. They will measure you on judgment latency—how long you wait before escalating. Too fast, and you’re seen as insecure. Too slow, and you’re seen as isolated. The sweet spot: escalate only after logging three attempted workarounds.

What compliance and regulatory training will I take as a new PM at Eli Lilly?

All new product managers complete 40 hours of mandatory compliance training within the first 21 days, including GxP, FDA promotional guidelines, and 21 CFR Part 11 for digital products.

In a Q3 2025 debrief, a PM was downgraded for referring to “user growth” in a launch plan. The correct term: “patient reach.” Language isn’t semantics—it’s regulatory exposure. Mislabeling a “feature” as a “treatment benefit” can trigger audit flags.

Training isn’t a formality. It’s a filter. One candidate in 2024 passed all interviews but failed the post-offer compliance simulation—a role-play where they had to correct a sales rep’s off-label messaging. They responded with “let me check the FAQ,” not “that statement violates FDA 201.80.” They were not hired.

Not all PMs take the same modules. If your product touches clinical data, you’ll take Data Integrity & ALCOA+ (5 hours). If you’re on a digital companion app, you’ll take HIPAA-Pharma Hybrid Scenarios (8 hours). Skipping any section delays system access.

The deeper principle: at Lilly, every decision must be reconstructable. That means version-controlled documents, audit trails on all Slack decisions, and no unilateral approvals. Your Jira tickets will require dual approvers—one from medical, one from legal—until you pass the Risk Decision Framework exam.

How are goals set for new PMs during onboarding?

Your first 90-day goals are not yours to write. They are drafted by your manager, reviewed by HRBP, and aligned to your grade level (typically IC-4 or IC-5). Typical goals include: complete 8 stakeholder interviews, lead 1 cross-functional risk assessment, and deliver a launch readiness scorecard with zero critical findings.

In 2025, a new PM proposed a “user adoption sprint” as a goal. It was rejected. Not because it was bad—but because “adoption” is a commercial metric, not a PM deliverable. Your goal must be tied to process fidelity, not outcome velocity.

The problem isn’t ambition—it’s misalignment. At Lilly, “success” for a new PM isn’t speed to market. It’s reduction of cross-functional rework. One PM in diabetes devices was rated “exceeds” after cutting legal review cycles from 14 days to 9 by pre-loading templates.

Goals are binary: complete or not complete. No “80% done.” No “working on it.” You either closed the risk log item or you didn’t. This is not agile theater. It’s GxP accountability.

Not all goals are visible at day 1. Some are released after training completion. For example, you can’t own a labeling change until you pass the Regulatory Writing Basics module. Progress is gated, not linear.

What cross-functional teams will I work with in the first 90 days?

You will formally engage at minimum with Medical Affairs, Regulatory, Legal, Safety, Commercial Operations, and Manufacturing. Informally, you’ll need access to Clinical Development and Pharmacovigilance.

In a 2025 post-mortem, a PM assumed Legal would review promotional copy in 3 days. It took 11. The delay wasn’t bureaucracy—it was the PM’s failure to submit the template in the approved format (Word, not Google Docs, with tracked changes enabled). The issue wasn’t the team—it was the interface design.

Not every team has equal pull. Medical Affairs can block a launch. Safety can halt a feature. Commercial can delay a test market. Your job is not to “manage up”—it’s to map influence. One PM in oncology succeeded by identifying the unspoken veto holder: the Global Safety Lead, not the named stakeholder in the org chart.

The deeper insight: at Lilly, teams don’t “collaborate.” They “coordinate under protocol.” You don’t schedule a meeting—you initiate a coordination event with a pre-circulated agenda, required attendees, and a designated scribe. No ad hoc syncs. No Zoom drop-ins.

Your first 30 days should include one shadowing session per core team. Sit in on a safety signal review. Attend a regulatory submission prep call. Watch how Medical Affairs responds to HCP inquiries. You’re not there to contribute—you’re there to calibrate.

How is performance evaluated for PMs in the first 90 days?

Performance is evaluated on three dimensions: compliance adherence (40%), stakeholder credibility (30%), and decision hygiene (30%). You don’t get scored on roadmap delivery—you get scored on whether your decisions can survive an audit.

In a 2024 hiring committee discussion, a PM was rated “at expectations” despite shipping two features early. Why? They bypassed the Brand Governance forum and used an unapproved claim in a slide deck. Output was high. Integrity was low.

Not all feedback is documented. Much of it is ambient: how often teams volunteer to work with you, whether your meeting invites are accepted, if your emails get replies within 24 hours. One PM failed because their cross-functional partners consistently CC’d their manager—clear signal of distrust.

The review is not a formality. It involves a 90-minute panel with your manager, HRBP, and a peer from another franchise. You present a single artifact—typically your risk log—and defend every entry. No slides. No storytelling. Just traceability.

The problem isn’t your work—it’s your paper trail. One PM lost points because they resolved a risk verbally. The system required a documented decision matrix with alternatives considered. At Lilly, if it’s not written, it didn’t happen.

Preparation Checklist

Complete all pre-day-one compliance modules in the Lilly Learning Hub (delays past day 5 block system access)
Map your core team’s org structure and escalation paths—include dotted-line and behind-the-scenes influencers
Schedule stakeholder interviews with Medical, Regulatory, Legal, and Safety leads by day 10
Attend one live safety signal review and one regulatory submission prep session by day 21
Draft a risk log template using the Global Product Development (GPD) framework
Work through a structured preparation system (the PM Interview Playbook covers pharma PM onboarding with real debrief examples from Lilly, J&J, and BMS)
Prepare a 90-day plan that emphasizes process over product—highlight training, coordination events, and compliance gates

Mistakes to Avoid

BAD: Sending a Jira roadmap to stakeholders on day 12

One PM did this in 2025. The backlash wasn’t about the tool—it was the implication that engineering velocity mattered more than medical review cycles. GOOD: Share a draft process map of how decisions flow from concept to approval, with handoff points and compliance checkpoints.

BAD: Using tech PM terms like “MVP” or “growth hacking” in meetings

In a launch planning session, a new hire said “let’s A/B test the patient onboarding.” The room went quiet. A/B testing without IRB approval violates ethical guidelines. GOOD: Frame tests as “controlled pilot evaluations” with predefined endpoints and safety monitoring.

BAD: Escalating a blocked decision without documenting three mitigation attempts

One PM stalled for 10 days, then escalated to VP level. The response: “Show me your log of attempts.” No log existed. GOOD: Maintain a running decision journal—what you tried, who you contacted, what was the outcome. At Lilly, effort isn’t assumed—it’s proven.

FAQ

What salary range should I expect as a new PM at Eli Lilly in 2026?

IC-4 PMs start at $135,000–$145,000 with a 10–12% bonus; IC-5 at $155,000–$165,000 with 15%. Location adjustments apply—Indianapolis base is flat; New York or San Diego adds 8–12%. Equity is rare for non-executive PMs. The problem isn’t compensation—it’s your benchmark. Most regret comparing to tech PM packages without factoring in lower burnout and structured progression.

Will I have to relocate to Indianapolis?

Not necessarily. Lilly has PM hubs in Indianapolis, San Diego (biotech), and New York (digital health). Hybrid is standard: 2 days office for core team alignment. Fully remote is rare unless on a global digital product. The issue isn’t location—it’s presence. If your team is in Indianapolis and you’re remote in Seattle, you’ll miss informal coordination cues that happen in hallways.

Can I transition to a tech PM role after 2 years at Lilly?

Yes, but not directly. Former Lilly PMs who moved to tech reported needing 3–6 months to “unlearn compliance paralysis.” The reverse is harder: tech PMs struggle with Lilly’s decision latency. The insight: Lilly builds judgment under constraint. That skill is valuable—but not transferable without translation. Don’t frame your experience as “slow”—frame it as “auditable.”

Ready to build a real interview prep system?

Get the full PM Interview Prep System →

The book is also available on Amazon Kindle.